510(k) Report

510(k) · Cleared

Cleared

TEA Device

K230526510(k) TraditionalCleared Sep 14, 2023199-day reviewClass II21 CFR 876.5340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Transtimulation Research, Inc. · QHH Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs)

Cleared on Sep 14, 2023 as substantially equivalent to DEN180057 (Innovative Health Solutions (Ihs), Inc., 2019) after a 199-day review. Its family tree reaches back 1 generation to 2019.

Decided
Sep 14, 2023
Review
199 days
Class
Class II
Product code
QHH
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN180057 (2019). No later device cites it as a predicate yet.

DEN180057 · IB-Stim · Innovative Health Solutions (Ihs), Inc. · 20190
  1. Root · 1 generation backDEN180057 IB-StimInnovative Health Solutions (Ihs), Inc. · 2019
  2. This deviceK230526 TEA DeviceTranstimulation Research, Inc. · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN180057IB-StimInnovative Health Solutions (Ihs), Inc.2019—
0 (this device)K230526TEA DeviceTranstimulation Research, Inc.2023—
FIG. 1 — Lineage of K230526, 2019–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QHH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QHH device

  1. #1 K250451 NeurAxis IB-Stim (01-1020)score 12.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN180057IB-Stim
Summary page 5
…ice The predicate and reference device are listed below: Predicate Device Reference Device 510(k) DEN180057 K212377 Number Transcutaneous Electrica…
Innovative Health Solutions (Ihs), Inc.2019—
†K212377Transcutaneous Electrical Applicator (TEA), Model SNM-FDC01Ningbo Medkinetic Medical Device Co., Ltd.2022—

Also cleared against DEN180057: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate DEN180057.

How does its category compare?

All QHH devices

QHH Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs): FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QHH

2in 2025

2019: 12020: 12023: 12024: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QHH

Too few QHH 510(k)s in any year since 2007 to give a median.

Recalls per year · QHH

No recall names QHH since 2007.

Adverse event reports per year · QHH

2in 2023

2023: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code QHH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20191—00
20201—00
20210—00
20220—00
20231—02
20241—00
20252—00
20260—0—

What is it indicated for?

The Transcutaneous Electrical Applicator (TEA) is a transcutaneous electrical nerve field stimulator system intended to be used in adult patients with functional abdominal pain associated with irritable bowel syndrome (IBS) through application to Cranial Nerves V, VII, IX and X, and the occipital nerves, as an aid in the reduction of pain when combined with other therapies for IBS. TEA device is intended to be used for 7-120 hours per week up to 3 consecutive weeks.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K230526: TEA Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230526

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026